EP2616547A1 - Process for production of l-fucose - Google Patents

Process for production of l-fucose

Info

Publication number
EP2616547A1
EP2616547A1 EP11769803.5A EP11769803A EP2616547A1 EP 2616547 A1 EP2616547 A1 EP 2616547A1 EP 11769803 A EP11769803 A EP 11769803A EP 2616547 A1 EP2616547 A1 EP 2616547A1
Authority
EP
European Patent Office
Prior art keywords
fucose
fermentation
glucose
polysaccharide
ppm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11769803.5A
Other languages
German (de)
French (fr)
Inventor
Alessandro Gori
Silvia Biagiolini
Marco Manoni
Luana Vagnoli
Liana Salsini
Jacopo Chini
Silvia Giacomelli
Giovanni Cipolletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inalco SpA
Original Assignee
Inalco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inalco SpA filed Critical Inalco SpA
Publication of EP2616547A1 publication Critical patent/EP2616547A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13KSACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K13/00Sugars not otherwise provided for in this class
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Definitions

  • the present invention relates to a process for the production, on an industrial scale, of L-fucose (or 6-deoxygalactose) by hydrolysis of a polysaccharide produced by a fermentation process effected by a novel isolated microbial strain belonging to the family Enterobacteriaceae.
  • Fucosylated oligosaccharides and polysaccharides are of great interest to the chemical, pharmaceutical, cosmetic and nutraceutical industry. Fucosylated oligosaccharides and polysaccharides are known to have potential medical applications as anti-tumour and anti-inflammatory agents but also potential cosmetic applications as anti-ageing agent for the skin that is able to improve skin tonicity.
  • Fucosyl derivatives for which L-fucose represents the raw material, are of industrial interest for their known antiallergic, hydrating, emulsifying and stabilizing properties.
  • Another very important use of L-fucose is as a precursor of semisynthetic analogues of the fucosylated oligosaccharides contained in human milk (human milk oligosaccharides).
  • the production of L-fucose industrially is still rather problematic both with respect to chemical and biochemical synthesis, and conversely with respect to the use of bacterial strains that produce L-fucose or polysaccharides containing L-fucose by fermentation.
  • EP0102535 describes the fermentation of bacteria of the genera Alcaligenes, Klebsiella, Pseudomonas or Enterobacter for producing extracellular polysaccharides rich in rhamnose or fucose. These deoxy-sugars can, after acid hydrolysis of the polysaccharide, be isolated from the hydrolysate.
  • the L-fucose currently on the market is obtained from natural sources, in particular by acid hydrolysis of sulphated polysaccharides such as fucoidans extracted from algae such as Laminaria.
  • sulphated polysaccharides such as fucoidans extracted from algae such as Laminaria.
  • direct extraction from algae is expensive and is moreover subject to seasonal variations in volumes and product quality.
  • L-fucose Another source of L-fucose is the bark of trees with a high trunk such as willow, birch and beech. In this case too, L-fucose is extracted by hydrolysis, with low yields and high costs.
  • the present invention solves the aforementioned problems by means of a new bacterial strain belonging to the family Enterobacteriaceae, identified as C2B2, isolated from foliar extract of Phalaenopsis sp.
  • Fig.1 shows the plot of a 1 H-NMR spectrum (in deuterated water, performed at 25°C with acetonitrile internal standard at 2.06ppm) of a fucose-containing polysaccharide, produced by a bacterial strain according to the invention (as from example 6)
  • Fig.2 shows the plot of a 13 C-NMR spectrum (in deuterated water, performed at 25°C with acetonitrile internal standard at 1 .470ppm) of a fucose-containing polysaccharide, produced by a bacterial strain according to the invention (as from example 6)
  • Fig.3 shows the plot of a 13 C-NMR spectrum (in deuterated water, performed at 25°C with acetonitrile internal standard at 1 .470ppm) of the anomeric region of a fucose- containing polysaccharide, produced by a bacterial strain according to the invention (as from example 6)
  • Fig.4 shows an HPLC plot of a partial hydrolysis mixture of a polysaccharide according to the invention (as from example 7)
  • Fig.5 shows an HPLC plot of a partial hydrolysis mixture of a polysaccharide according to the invention, which was then treated with ion exchange resins to eliminate the peak at about 1 1 minutes (as from example 7).
  • Fig.6 shows an HPLC plot of a complete hydrolysis mixture of a polysaccharide according to the invention (as from example 8)
  • Fig.7 shows an HPLC plot of a partial hydrolysis mixture of a polysaccharide according to the invention (as from example 9)
  • the C2B2 bacterial strain was isolated from foliar extract of orchids of the genus Phalaenopsis.
  • the new strain isolated was identified as belonging to the family Enterobacteriaceae and was designated C2B2.
  • the new strain was deposited at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) (German Collection of Microorganisms and Cell Cultures), Inhoffenstr. 7 B, D-38124, Braunschweig (Germany) on 23 January 2009 in accordance with the provisions of the Budapest Treaty.
  • DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
  • the new microbial strain was assigned the accession number DSM 22227.
  • the microbial strain according to the invention was characterized by sequencing the ribosomal RNA 16S resulting in a SEQ ID NO: 1 given below:
  • the present invention also relates to microbial strains belonging to the family Enterobacteriaceae, comprising a sequence rRNA 16S containing a sequence with homology greater than or equal to 93% with SEQ. ID NO: 1 ; preferably said homology is greater than or equal to 98% with SEQ. ID NO: 1 .
  • the present invention also relates to mutated strains derived from the C2B2 strain.
  • These strains can be obtained by simple selection of strains spontaneously mutated and isolated from a culture of C2B2 or by selection of strains derived from C2B2 by the action of mutagenic factors, such as UV radiation or X-rays, or by the action of chemicals such as ozone, nitrous acid, N-methyl-N'-nitro-N-nitrosoguanidine (NTG) or ethane methane sulphonate (EMS).
  • mutagenic factors such as UV radiation or X-rays
  • chemicals such as ozone, nitrous acid, N-methyl-N'-nitro-N-nitrosoguanidine (NTG) or ethane methane sulphonate (EMS).
  • said derived or mutated microbial strain comprises an rRNA 16S sequence containing a sequence having homology with SEQ. ID NO: 1 equal or greater than 98%.
  • the C2B2 bacterial strain according to the invention has the following morphological and biochemical characteristics:
  • the present invention also relates to the fermentation process developed for the production of extracellular polysaccharides containing L-fucose and the subsequent isolation of 6-deoxy sugar.
  • the C2B2 strain is grown by inoculation in any fermentable aqueous medium containing carbon and nitrogen sources and mineral salts.
  • the source of assimilable carbon is represented by one or more sugars (for example glucose, fructose, maltose, sucrose, starch, mannitol, sorbitol, lactose, corn syrup etc.) alone or mixed.
  • sugars for example glucose, fructose, maltose, sucrose, starch, mannitol, sorbitol, lactose, corn syrup etc.
  • glucose is a preferred carbon source.
  • the nitrogen source used can be proteinaceous material of various types (for example yeast extract, soya flour, hydrolysed proteins, corn steep liquor etc.). Typically the nitrogen source is between 0.05 and 0.5 wt.% in the medium.
  • Various salts that are normally used in nutrient media can be used.
  • Non-limiting examples are: phosphates, sulphates, chlorides, sodium carbonate, potassium, ammonium, calcium and magnesium.
  • the fermentation can be carried out at temperatures between 25 and 35 °C, preferably 30°C, at a pH between 6.0 and 7.5 maintained by means of systems for automatic correction, with aeration and agitation, for a period of 2-5 days.
  • L-fucose The formation of L-fucose is monitored by HPLC on samples submitted beforehand to complete acid hydrolysis; macroscopically it is possible to assess the progress of fermentation on the basis of the viscosity, which, in a medium where the expected quantity of polysaccharide is being formed, reaches and even exceeds 2200 cP as described in the literature (P.T. Vanhooren et al. Med. Fac. Landbouww. Univ. Gent., vol. 62/4a, p. 1271 -1276, 1997).
  • Fermentation can be carried out in conventional fermenters by inoculating the nutrient medium with a culture of the C2B2 strain. Prior to inoculation the nutrient medium is sterilized, for example by heat at temperatures of the order of 120°C.
  • the culture suspension is submitted to suitable treatments for the purpose of purification and recovery of L-fucose.
  • NMR spectra (not shown) acquired for example at a temperature of 40°C also show anomeric signals at about 4.7ppm and about 4.6ppm in approx. 1 :1 ratio and attributable to bonds of the beta type.
  • the polysaccharides obtained from fermentation of the C2B2 strain preferably have, moreover, 1 H-NMR signals at about 1 .4ppm (broad singlet) (1 .435ppm in Fig. 1 ) and 13 C-NMR signals at about 25.7ppm (25.773ppm in Fig. 2) indicative of the presence of a pyruvate group with a bridge bond between two hydroxyls.
  • the anomeric zone of the carbon spectrum may, moreover, preferably show from a minimum of 4 to a maximum of 6 signals, between 97 and 105ppm.
  • the polysaccharides obtained from fermentation of the C2B2 strain can moreover optionally also have other signals attributable to the probable presence of O-acetyl groups such as for example signals at 2.06ppm, 2.148ppm and 2.201 ppm in the 1 H spectrum (see Fig. 1 ) and signals at about 20ppm (20.958ppm in Fig. 2) and at about 174ppm (173.866ppm in Fig. 2) in the 13 C spectrum.
  • one or more sugars making up the polysaccharide can be bound to one or more pyruvate groups with a bridge bond between two hydroxyls, and moreover the polysaccharide can be in non-acetylated form or can have one or more acetyls on one or more monomers.
  • Fig. 1 and Fig. 2 show, respectively, the 1 H- and 13 C-NMR spectra of a polysaccharide (or mixture of polysaccharides) obtained as a result of aerobic fermentation of the C2B2 strain as described above.
  • the spectra were obtained using the model VXR300S NMR Spectrometer (Varian Inc., Palo Alto CA, USA).
  • Said polysaccharide (or mixture of polysaccharides), if submitted to acid hydrolysis by for example treatment with sulphuric acid at 50-96% (for example carried out at the reflux temperature for 30 min-10 hours) or treatment with trifluoroacetic acid (TFA) at concentrations of 10-60% at the reflux temperature for 20 min-2 hours (in the case of TFA it is possible to work at pressures above atmospheric, for example up to about 2 atm as is obtainable in autoclave)
  • a hydrolysis mixture is obtained consisting of the following principal monosaccharides, which can be separated by HPLC (Perkin Elmer with Transgenomic Column ICE SEP Ion 300, eluent 0.015 N sulphuric acid, column temperature: 40°C, flow: 0.4 ml/min). (see Fig. 4)
  • Fig. 5 shows the HPLC plot (Perkin Elmer HPLC with Transgenomic Column ICE SEP Ion 300, eluent 0.015 N sulphuric acid, column temperature: 40°C, flow: 0.4 ml/min) obtained as a result of partial acid hydrolysis.
  • ion exchange resins Rost and Haas, Amberlite IR 120 and Amberlite IRA 94S
  • the aforementioned hydrolysed polysaccharide therefore provides mixtures containing mainly L-fucose, D-glucose, D-galactose and preferably also glucuronic acid and pyruvic acid, and from these mixtures it is possible to isolate the desired L-fucose at high yields and purities.
  • the aforementioned polysaccharide After partial hydrolysis, the aforementioned polysaccharide has, according to HPLC analysis of the hydrolysate, preferably a molar content of glucose/galactose/fucose/pyruvic acid in the relative proportions 0.5 : 0.5 : 1 : 0.5
  • the aforementioned polysaccharide has, according to HPLC analysis of the hydrolysate, preferably a molar content of glucose/galactose/fucose/glucuronic acid/pyruvic acid in the relative proportions of 0.5 : 1 : 1 : 0.5 : 0.5.
  • the mixture at the end of fermentation is fluidized until a viscosity below 100 cP is reached, by adding an aqueous solution of a strong acid, preferably sulphuric acid, preferably with a concentration between 30 and 70 wt.%, up to a pH between 1.5 and 4.5, preferably between 2.0 and 3.0.
  • a strong acid preferably sulphuric acid
  • the acidified mixture is then heated at temperatures between 60 and 80°C, for times between 2 and 10 hours, preferably for 4-8 hours.
  • the first purification step is another crucial point of the process: the polysaccharide is recovered by ultrafiltration since it remains quantitatively in the retentate together with just the cells of the microorganism while all the fermentation by-products (e.g. butanediol, lactic acid etc.) and the salts and the acid added for fluidization are removed almost quantitatively in the permeate.
  • the fermentation by-products e.g. butanediol, lactic acid etc.
  • This step provides an excellent solution to the problem of purification of L-fucose, for obtaining a crystalline product of high purity; in fact it allows the sugars constituting the polysaccharide to be separated from all the low molecular weight by-products, for example butanediol, that cannot be removed in the steps described next, and that constitute a great problem for direct crystallization of the product, as they are present in considerable amounts.
  • the purification process is carried out on the retentate containing the polysaccharide according to known procedures (see for example EP102535, H. Voelskow and M. Schlingmann).
  • Complete hydrolysis is performed by treatment with a strong acid (for example sulphuric acid, hydrochloric acid, phosphoric acid, trifluoroacetic acid etc.). Sulphuric acid is preferred.
  • a solution of strong acid at 30-70 wt.% is added to the retentate and it is heated at the reflux temperature for 5-10 hours.
  • a base sodium hydroxide, calcium hydroxide etc.
  • Calcium hydroxide is preferred.
  • sulphuric acid and calcium hydroxide are used in combination: this leads to precipitation of CaS0 4 , which is removed by filtration or by centrifugation, thus removing a large part of the salts present in the reaction mixture.
  • D-glucose and D-galactose and glucuronic acid from the mixture is achieved by techniques known by a person skilled in the art, for example by chromatography or, preferably, by the action of a microorganism that utilizes said carbohydrates as a carbon source for growing, but leaves the L-fucose intact.
  • a microorganism is used and even more preferably the solution is inoculated with Saccharomyces cerevisiae.
  • Fermentation is conducted until glucose and galactose and glucuronic acid disappear completely.
  • the solution is then pasteurized at 60-70°C for 10-30 minutes and the yeast cells are removed from the solution of L-fucose by ultrafiltration or microfiltration, and the ultrafiltered or microfiltered solution is deionized by passing over strong cationic and weak anionic ion exchange resins in series.
  • the deionized solution is concentrated to a syrup and L-fucose (whose HPLC purity in the solution at this stage is above 75%) is crystallized by adding solvent, for example alcohols such as methanol, ethanol, n-propanol, isopropanol or 2-butanone.
  • solvent for example alcohols such as methanol, ethanol, n-propanol, isopropanol or 2-butanone.
  • the strain producing the polysaccharide containing L-fucose was isolated from 1 g of foliar homogenate of Phalaenopsis sp. (Orchidacea) in saline and diluted serially in the same solution to 10 ⁇ 8 . 1 ml of each dilution was seeded at depth in Petri dishes containing 15 ml of TSB medium (Trypticase Soy Broth, Biolife) solidified with 15g/l of agar and left to incubate at 30°C for three days.
  • TSB medium Trypticase Soy Broth, Biolife
  • the yellow pigmented colonies, clear and of large convex dimensions, that develop on the surface of the agar were then transferred to fresh TSB medium for purification by smearing them for three successive cycles, starting each time from a well isolated colony.
  • the strain was submitted to summary identification by the usual methods of biochemical characterization (API tests) and by sequencing the ribosomal RNA 16S (SEQ ID NC ).
  • the purified strain was stored in glycerol both at -20°C and at -80 °C.
  • HPLC analysis of the hydrolysate produces the following results (comparing only the content of glucose, galactose and fucose after hydrolysis of the fermentation broth without treatments of purification and isolation of the components)
  • Glucose:Galactose:Fucose The molar proportions of Glucose:Galactose:Fucose are thus found to be 1 .8 : 1 : 1 .3.
  • 1 10 I of culture medium is prepared, composed of:
  • Inoculate with 3 litres of preferment prepared according to Example 2 and leave to stand at 30°C, stirring vigorously, blowing-in air from below, at slight pressure, monitoring the glucose concentration.
  • glucose is absent, add 5.5 litres of a sterile solution of glucose at 50% w/v, monitoring the pH, which must be at 7.0 ⁇ 0.3, and the viscosity of the medium.
  • Glucose:Galactose:Fucose The molar proportions of Glucose:Galactose:Fucose are found to be: 3.4 : 1 : 2.2
  • the preferment is left at 30°C with stirring, blowing-in air from below and under slight pressure for about 24 hours.
  • the molar proportions of Glucose:Galactose:Fucose in the preferment are found to be: 3.1 : 1 : 1 .7
  • the fermentation takes a total of 140 hours.
  • the molar proportions of Glucose:Galactose:Fucose are found to be 2.7 : 1 : 2.0
  • Example 4 15 m 3 of ferment obtained from Example 4 (containing 28 kg of L-fucose) is ultrafiltered for the purpose of separating and concentrating the polysaccharide. 315 kg of 50% sulphuric acid is added to the retentate from ultrafiltration, maintaining the suspension under reflux for 8 hours in a suitable reactor, for complete hydrolysis of the polysaccharide.
  • the suspension is adjusted to pH 5.5-6.5, by adding 180 kg of calcium hydroxide.
  • the precipitate of calcium sulphate that forms after adding calcium hydroxide is removed by centrifugation.
  • the supernatant is then adjusted to 37 °C, and inoculated with 2 kg of lyophilized yeast Saccharomyces cerevisiae.
  • the solution is then pasteurized at 70°C for 30 minutes and ultrafiltered.
  • the ultrafiltration permeate is deionized on strong cationic and weak anionic ion exchange resins in series.
  • the fermentation of the C2B2 strain was carried out as in example 4.
  • the solution was then concentrated and diafiltered by ultrafiltration with a polymer membrane with a molecular cut-off of 10 000 Da.
  • Glacial acetic acid was added to the supernatant until a final concentration of 2% was reached. The sample was then heated at 100 ⁇ € for 1 hour.
  • the sample was centrifuged again at 13000 rpm for 30 minutes and, after dilution 1 :1 with water, it was diafiltered against demineralized water and concentrated by tangential ultrafiltration with a spiral-wound membrane with molecular cut-off of 20000 Da.
  • the concentrate was dried to constant weight in a rotary evaporator (Rotovapor, Buchi). 5 grams of sample was treated with trifluoroacetic acid (TFA) to a final concentration of 16% in autoclave (2 atm) at 121 °C for 20 minutes. The solution obtained was exchanged with 100 ml of demineralized water by means of the rotary evaporator (Rotovapor, Buchi) 5 times.
  • TFA trifluoroacetic acid
  • the sample was then submitted to HPLC chromatographic analysis using the Perkin Elmer series 200 HPLC chromatograph, chromatographic column Transgenomic ICE- SEP ION 300 equipped with similar precolumn and refractive index detector with thermostatically controlled cells.
  • chromatogram given in Fig.5 shows the HPLC plot obtained in the same conditions on the same sample after elimination of the peak at 11 by passing over ion exchange resins.
  • the fermentation of the C2B2 strain was carried out as in example 4.
  • the solution obtained was ultrafiltered by filtration on a ceramic filter with cut-off of 300 000 Da (0.05 micron) and the permeate was concentrated using a nanofiltration membrane (SR2 membrane).
  • SR2 membrane nanofiltration membrane
  • the polysaccharide was then precipitated with methanol (final concentration methanol :water of 3:1 ).
  • the precipitate was finally filtered on a paper filter, washed with a solution of methanol :water 3:1 and dried in a stove at 40°C for 8 hours.
  • the sample was then submitted to HPLC chromatographic analysis using the Perkin Elmer series 200 HPLC chromatograph, chromatographic column Transgenomic ICE- SEP ION 300 equipped with similar precolumn and refractive index detector with thermostatically controlled cells.
  • Peak Time ; Component Concentration Area Response i Amount Area
  • the fermentation of the C2B2 strain was carried out as in example 4.
  • the solution was then heated at 97 °C for 6 hours.
  • the sample was then submitted to HPLC chromatographic analysis using the Perkin Elmer series 200 HPLC chromatograph, chromatographic column Transgenomic ICE- SEP ION 300 equipped with similar precolumn and refractive index detector with thermostatically controlled cells.
  • chromatogram is shown in Fig. 7. (see printout below)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention relates to a process for production, on an industrial scale, of L- fucose (or 6-deoxygalactose) from hydrolysis of polysaccharides obtainable by means of aerobic fermentation of a new isolated microbial strain belonging to the family Enterobacteriaceae.

Description

PROCESS FOR PRODUCTION OF L-FUCOSE
FIELD OF THE INVENTION
The present invention relates to a process for the production, on an industrial scale, of L-fucose (or 6-deoxygalactose) by hydrolysis of a polysaccharide produced by a fermentation process effected by a novel isolated microbial strain belonging to the family Enterobacteriaceae.
PRIOR ART
L-Fucose, and fucosylated oligosaccharides and polysaccharides are of great interest to the chemical, pharmaceutical, cosmetic and nutraceutical industry. Fucosylated oligosaccharides and polysaccharides are known to have potential medical applications as anti-tumour and anti-inflammatory agents but also potential cosmetic applications as anti-ageing agent for the skin that is able to improve skin tonicity.
Fucosyl derivatives, for which L-fucose represents the raw material, are of industrial interest for their known antiallergic, hydrating, emulsifying and stabilizing properties. Another very important use of L-fucose is as a precursor of semisynthetic analogues of the fucosylated oligosaccharides contained in human milk (human milk oligosaccharides). The production of L-fucose industrially is still rather problematic both with respect to chemical and biochemical synthesis, and conversely with respect to the use of bacterial strains that produce L-fucose or polysaccharides containing L-fucose by fermentation.
The known chemical syntheses, which often involve the configuration inversion of a sugar that is readily available, always envisage numerous steps and the use of very expensive reagents (J. -P. Gesson et al. Tetrahedron Letters, vol. 33, No. 25, p. 3637- 3640, 1992, G. D. Gamalevich et al. Tetrahedron, vol. 55, p. 3665-3674, 1999, S. Sarbajna et al. Carbohydr. Res., vol. 270, p. 93-96, 1995).
In US 6,713,287 C.-H. Wong prepares L-fucose enzymatically: in this case the process is based on the use of engineered microorganisms, which express the enzymes necessary for synthesizing L-fucose starting from dihydroxyacetone and lactaldehyde. The processes for formation of L-fucose by fermentation are also known. Some microbial extracellular polysaccharides (EPS), better known for their properties as thickening, gelling or emulsifying agents, constitute an attractive source of L-fucose. The description of a strain of Klebsiella K-63 that produces a capsular polysaccharide containing D-galactose, L-fucose and D-galacturonic acid in a molar ratio of 1 :1 :1 dates from the end of the 1970s (J. P. Joseleau et al. Carbohyd. Res., vol. 77, p. 183-190, 1979).
In US 4,298,691 , G.T. Veeder and K.S. Kang describe a process for producing a heteropolysaccharide S-156 starting from a strain of Klebsiella pneumonie ATCC 31646 containing galacturonic acid, D-galactose and L-fucose in a molar ratio of 23:21 :26.
EP0102535 describes the fermentation of bacteria of the genera Alcaligenes, Klebsiella, Pseudomonas or Enterobacter for producing extracellular polysaccharides rich in rhamnose or fucose. These deoxy-sugars can, after acid hydrolysis of the polysaccharide, be isolated from the hydrolysate.
Interesting results have been obtained with the use of Clavibacter michiganensis which in about 8 days of fermentation is able to produce about 2.4g/l of L-fucose: however, Clavibacter is a phytopathogen and so cannot be used industrially (P.T. Vanhooren et al. Med. Fac. Landbouw. Univ. Gent, vol. 62/4a, p. 1271 -1276, 1997).
The L-fucose currently on the market is obtained from natural sources, in particular by acid hydrolysis of sulphated polysaccharides such as fucoidans extracted from algae such as Laminaria. However, direct extraction from algae is expensive and is moreover subject to seasonal variations in volumes and product quality.
Another source of L-fucose is the bark of trees with a high trunk such as willow, birch and beech. In this case too, L-fucose is extracted by hydrolysis, with low yields and high costs.
It is therefore clearly necessary to provide a process, at least as an alternative, using microbial fermentation, for production of L-fucose that is applicable on an industrial scale and that is efficient and reproducible. SUMMARY OF THE INVENTION
The present invention solves the aforementioned problems by means of a new bacterial strain belonging to the family Enterobacteriaceae, identified as C2B2, isolated from foliar extract of Phalaenopsis sp.
Isolation of this new strain made it possible to develop aerobic fermentation which, surprisingly, leads to the formation of a polysaccharide containing L-fucose in amounts such that, once the polymer has been hydrolysed, the concentration of L-fucose in the fermentation broth is above 3g/l (the amount of L-fucose is evaluated by HPLC after complete hydrolysis of a sample to which 96% sulphuric acid has been added in amounts such as to give a 1 .5 M solution, which is then heat-treated at 100°C for 30 minutes).
Then, after several purification steps, crystalline L-fucose can be recovered from the fermentation broth at high yields (above 75%) and with HPLC purity>98%. BRIEF DESCRIPTION OF THE DRAWINGS
Fig.1 shows the plot of a 1 H-NMR spectrum (in deuterated water, performed at 25°C with acetonitrile internal standard at 2.06ppm) of a fucose-containing polysaccharide, produced by a bacterial strain according to the invention (as from example 6)
Fig.2 shows the plot of a 13C-NMR spectrum (in deuterated water, performed at 25°C with acetonitrile internal standard at 1 .470ppm) of a fucose-containing polysaccharide, produced by a bacterial strain according to the invention (as from example 6)
Fig.3 shows the plot of a 13C-NMR spectrum (in deuterated water, performed at 25°C with acetonitrile internal standard at 1 .470ppm) of the anomeric region of a fucose- containing polysaccharide, produced by a bacterial strain according to the invention (as from example 6)
Fig.4 shows an HPLC plot of a partial hydrolysis mixture of a polysaccharide according to the invention (as from example 7)
Fig.5 shows an HPLC plot of a partial hydrolysis mixture of a polysaccharide according to the invention, which was then treated with ion exchange resins to eliminate the peak at about 1 1 minutes (as from example 7). Fig.6 shows an HPLC plot of a complete hydrolysis mixture of a polysaccharide according to the invention (as from example 8)
Fig.7 shows an HPLC plot of a partial hydrolysis mixture of a polysaccharide according to the invention (as from example 9)
DETAILED DESCRIPTION OF THE INVENTION
The C2B2 bacterial strain was isolated from foliar extract of orchids of the genus Phalaenopsis. The new strain isolated was identified as belonging to the family Enterobacteriaceae and was designated C2B2. The new strain was deposited at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) (German Collection of Microorganisms and Cell Cultures), Inhoffenstr. 7 B, D-38124, Braunschweig (Germany) on 23 January 2009 in accordance with the provisions of the Budapest Treaty.
The new microbial strain was assigned the accession number DSM 22227.
The microbial strain according to the invention was characterized by sequencing the ribosomal RNA 16S resulting in a SEQ ID NO: 1 given below:
CCAAGCAGCTTGCTGCTTCGCTGACGAGTGGCGGACGGGTGAGTAATGTCTGGG AAACTGCCTGATGGAGGGGGATAACTACTGGAAACGGTAGCTAATACCGCATAAC GTCGCAAGACCAAAGAGGGGGACCTTCGGGCCTCTTGCCATCAGATGTGCCCAGA TGGGATTAGCTAGTAGGTGGGGTAACGGCTCACCTAGGCGACGATCCCTAGCTGG TCTGAGAGGATGACCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGG AGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCG CGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGGGGAGGAAGGCGA TGYGGTTAATAACCGCGTCGATTGACGTTACCCGCAGAAGAAGCACCGGCTAACT CCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGG GCGTAAAGCGCACGCAGGCGGTCTGTCAAGTCGGATGTGAAATCCCCGGGCTCA ACCTGGGAACTGCATCCGAAACTGGCAGGCTTGAGTCTCGTAGAGGGGGGTAGAA TTCCAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGG CGGCCCCCTGGACGAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAG GATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTCGACTTGGAGGTTGTGCC CTTGAGGCGTGGCTTCCGGAGCTAACGCGTTAAGTCGACCGCCTGGGGAGTACG GCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGC ATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCTTGACATCCACAGA ACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTGTGAGACAGGTGCTGCATGGC TGTCGTCAGCTCGTGTTGTGAAATGTTGGGTTAAGTCCCGCAACGAGCGCAACCC TTATCCTTTGTTGCCAGCGGTYSGGCCGGGAACTCAAAGGAGACTGCCAGTGATA AACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGACCAGGGCT ACACACGTG CTACAATG G CG CATAC AAAG AG AAG CAATCTCG CG AG AG CTAG CG G ACCTCATAAAGTGCGTCGTAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGT CGGAATCGCTAGTAATCGTGAATCAGAATGTCACGGTGAATACGTTCCCGGGCCTT GTACACACCGCCCGTCACACCATGGGAGTGGGTTGCAAAAGAAGTAGGTAGCTTA ACCTTCGGGAGGGCGCTTACCACTTTGTGATTCATGACTGGG
The present invention also relates to microbial strains belonging to the family Enterobacteriaceae, comprising a sequence rRNA 16S containing a sequence with homology greater than or equal to 93% with SEQ. ID NO: 1 ; preferably said homology is greater than or equal to 98% with SEQ. ID NO: 1 .
The present invention also relates to mutated strains derived from the C2B2 strain. These strains can be obtained by simple selection of strains spontaneously mutated and isolated from a culture of C2B2 or by selection of strains derived from C2B2 by the action of mutagenic factors, such as UV radiation or X-rays, or by the action of chemicals such as ozone, nitrous acid, N-methyl-N'-nitro-N-nitrosoguanidine (NTG) or ethane methane sulphonate (EMS).
Preferaby said derived or mutated microbial strain, comprises an rRNA 16S sequence containing a sequence having homology with SEQ. ID NO: 1 equal or greater than 98%. The C2B2 bacterial strain according to the invention has the following morphological and biochemical characteristics:
□ Microscopic appearance: rods
□ Mobility: mobile strain.
□ Gram staining: negative staining.
□ Culture conditions: 25-35°C, aeration, agitation.
□ Culture in agar: colonies of mucoid appearance, pigmented (yellow). Characterization, both biochemical and by API-test by seeding of the colonies on specific culture media, gave the results described in Table 1 .
The present invention also relates to the fermentation process developed for the production of extracellular polysaccharides containing L-fucose and the subsequent isolation of 6-deoxy sugar.
The C2B2 strain is grown by inoculation in any fermentable aqueous medium containing carbon and nitrogen sources and mineral salts.
In general the source of assimilable carbon is represented by one or more sugars (for example glucose, fructose, maltose, sucrose, starch, mannitol, sorbitol, lactose, corn syrup etc.) alone or mixed. Typically the amount of sugars present in the medium is between 2 and 6 wt.%. For a preferred embodiment of the present invention, glucose is a preferred carbon source.
The nitrogen source used can be proteinaceous material of various types (for example yeast extract, soya flour, hydrolysed proteins, corn steep liquor etc.). Typically the nitrogen source is between 0.05 and 0.5 wt.% in the medium.
Various salts that are normally used in nutrient media can be used. Non-limiting examples are: phosphates, sulphates, chlorides, sodium carbonate, potassium, ammonium, calcium and magnesium.
TEST RESULT
Oxidases Negative
Catalases Positive
ONPG Positive
Arginine hydrolysis Negative
Lysine hydrolysis Negative
Ornithine hydrolysis Negative
Citrate assimilation Negative
H2S formation Negative
Urea hydrolysis Negative
Indole production Negative
Voges-Proskauer reaction Positive
Gelatin hydrolysis Negative
Glucose fermentation Positive
Mannitol fermentation Positive
Inositol fermentation Negative
Sorbitol fermentation Positive
Rhamnose fermentation Positive Sucrose fermentation Positive
Melibiose fermentation Positive
Amygdalin fermentation Positive
Arabinose fermentation Positive
Reduction of nitrates Positive
Table 1
The fermentation can be carried out at temperatures between 25 and 35 °C, preferably 30°C, at a pH between 6.0 and 7.5 maintained by means of systems for automatic correction, with aeration and agitation, for a period of 2-5 days.
The formation of L-fucose is monitored by HPLC on samples submitted beforehand to complete acid hydrolysis; macroscopically it is possible to assess the progress of fermentation on the basis of the viscosity, which, in a medium where the expected quantity of polysaccharide is being formed, reaches and even exceeds 2200 cP as described in the literature (P.T. Vanhooren et al. Med. Fac. Landbouww. Univ. Gent., vol. 62/4a, p. 1271 -1276, 1997).
Fermentation can be carried out in conventional fermenters by inoculating the nutrient medium with a culture of the C2B2 strain. Prior to inoculation the nutrient medium is sterilized, for example by heat at temperatures of the order of 120°C.
At the end of the fermentation time, the culture suspension is submitted to suitable treatments for the purpose of purification and recovery of L-fucose.
Fermentation conducted according to the procedure described above always provides polysaccharides whose 1 H- and 13C-NMR spectra comprise the following principal signals relating to the carbohydrate components (signals obtained according to the protocol described in the present invention):
1 ) 1 H-NMR signals at 1.3ppm (1.275ppm broad singlet, in Fig. 1 ) and 13C-NMR signals at 15.9ppm (15.989ppm, in Fig. 2): these two signals are diagnostic of the presence of fucose;
2) 1 H-NMR signals at 5.5ppm, 5.3ppm and 5.0ppm (respectively 5.480ppm, 5.340ppm and 4.986ppm in Fig. 1 ) of the anomeric zone in approximate quantitative ratio of
1 :2:1 to one another. These signals are compatible and attributable to anomeric signals of glycosides of the alpha type; 3) 13C-NMR signals, one signal at about 104.5ppm (104.558ppm as in Fig. 3) (compatible with the presence of a beta glucuronyl glycoside) and one at about "l OO.Oppm (100.009ppm as in Fig. 3) (attributable to alpha glycosides).
NMR spectra (not shown) acquired for example at a temperature of 40°C also show anomeric signals at about 4.7ppm and about 4.6ppm in approx. 1 :1 ratio and attributable to bonds of the beta type.
The polysaccharides obtained from fermentation of the C2B2 strain preferably have, moreover, 1 H-NMR signals at about 1 .4ppm (broad singlet) (1 .435ppm in Fig. 1 ) and 13C-NMR signals at about 25.7ppm (25.773ppm in Fig. 2) indicative of the presence of a pyruvate group with a bridge bond between two hydroxyls.
The anomeric zone of the carbon spectrum may, moreover, preferably show from a minimum of 4 to a maximum of 6 signals, between 97 and 105ppm.
The polysaccharides obtained from fermentation of the C2B2 strain can moreover optionally also have other signals attributable to the probable presence of O-acetyl groups such as for example signals at 2.06ppm, 2.148ppm and 2.201 ppm in the 1 H spectrum (see Fig. 1 ) and signals at about 20ppm (20.958ppm in Fig. 2) and at about 174ppm (173.866ppm in Fig. 2) in the 13C spectrum.
As a result, therefore, one or more sugars making up the polysaccharide (or mixture of polysaccharides) can be bound to one or more pyruvate groups with a bridge bond between two hydroxyls, and moreover the polysaccharide can be in non-acetylated form or can have one or more acetyls on one or more monomers.
As an example, Fig. 1 and Fig. 2 show, respectively, the 1 H- and 13C-NMR spectra of a polysaccharide (or mixture of polysaccharides) obtained as a result of aerobic fermentation of the C2B2 strain as described above.
The spectra were obtained using the model VXR300S NMR Spectrometer (Varian Inc., Palo Alto CA, USA).
Said polysaccharide (or mixture of polysaccharides), if submitted to acid hydrolysis by for example treatment with sulphuric acid at 50-96% (for example carried out at the reflux temperature for 30 min-10 hours) or treatment with trifluoroacetic acid (TFA) at concentrations of 10-60% at the reflux temperature for 20 min-2 hours (in the case of TFA it is possible to work at pressures above atmospheric, for example up to about 2 atm as is obtainable in autoclave) a hydrolysis mixture is obtained consisting of the following principal monosaccharides, which can be separated by HPLC (Perkin Elmer with Transgenomic Column ICE SEP Ion 300, eluent 0.015 N sulphuric acid, column temperature: 40°C, flow: 0.4 ml/min). (see Fig. 4)
-an HPLC peak corresponding to fucose (retention time of 18.52 minutes)
-an HPLC peak corresponding to galactose (retention time of 15.82 minutes)
-an HPLC peak corresponding to glucose (retention time of 14.63 minutes) In the case of partial hydrolysis (i.e. in milder conditions such as the conditions given in example 7 and in example 9) of the polysaccharide, a peak may also be found to be present at about 1 1 min retention time. This peak is called "peak at 1 1 " (in Fig. 4 it can be seen at a retention time of 10.62 minutes). Therefore, for the purposes of the present invention, hydrolysis that gives rise to detection of the peak at 1 1 by HPLC is called partial hydrolysis.
Based on the NMR analysis of this isolated peak and the enzymatic treatment with β- glucuronidase it is possible to ascribe the structure of a β-glucuronyl galactoside to the aforementioned disaccharide (Z.A. Popper et al., Phytochemistry, 2003, vol 64, p. 325- 335), very probably bound 1 -3.
If the hydrolysis conditions have given rise to a mixture also containing the disaccharide relating to the "peak at 1 1 ", this can be removed by treatment of the partial hydrolysis mixture with ion exchange resins. As an example, Fig. 5 shows the HPLC plot (Perkin Elmer HPLC with Transgenomic Column ICE SEP Ion 300, eluent 0.015 N sulphuric acid, column temperature: 40°C, flow: 0.4 ml/min) obtained as a result of partial acid hydrolysis. In this case the mixture obtained after hydrolysis was treated with ion exchange resins (Rohm and Haas, Amberlite IR 120 and Amberlite IRA 94S) to remove the peak at 1 1. In chromatographic conditions with higher resolution (for example separating the hydrolysis mixtures of the polysaccharide with Perkin Elmer HPLC, eluent 0.015 N sulphuric acid and Transgenomic chromatographic Column ICE SEP Ion 300 thermostatically controlled at 50 °C) the presence of another two chromatographic peaks may also be encountered:
- an HPLC peak corresponding to pyruvic acid (with a retention time of 16.70 minutes in
Fig. 7)
- an HPLC peak corresponding to glucuronic acid (with retention time of 13.94 minutes in Fig. 7)
The aforementioned hydrolysed polysaccharide (or mixture of polysaccharides) therefore provides mixtures containing mainly L-fucose, D-glucose, D-galactose and preferably also glucuronic acid and pyruvic acid, and from these mixtures it is possible to isolate the desired L-fucose at high yields and purities.
In particular
After partial hydrolysis, the aforementioned polysaccharide has, according to HPLC analysis of the hydrolysate, preferably a molar content of glucose/galactose/fucose/pyruvic acid in the relative proportions 0.5 : 0.5 : 1 : 0.5 After complete hydrolysis, the aforementioned polysaccharide has, according to HPLC analysis of the hydrolysate, preferably a molar content of glucose/galactose/fucose/glucuronic acid/pyruvic acid in the relative proportions of 0.5 : 1 : 1 : 0.5 : 0.5.
The proportions of the individual components were deduced (with due approximations) principally from the NMR data (Fig. 1 with signals at 1 .275ppm (fucose) and 1 .435 (pyruvic acid) in the ratio 1 :0.5), from the HPLC chromatograms in Fig. 4 (with calculated molar proportions between fucose (at 18.52 min), galactose (at 15.82) and glucose (at 14.63 min) in the approximate proportions 1 :0.5:0.5) and in Fig. 6 (with calculated molar ratios of fucose (at 18.74 min) to glucose (at 14.81 min) in the ratio of about 1 :0.5) and analysis of the isolated peak at 1 1 (data not shown) showing a ratio of galactose to glucuronic acid of 1 :1 . It should be noted that the complete hydrolysis of the peak at 1 1 should cause the liberation of galactose (therefore the content of galactose in a complete hydrolysate is doubled to give a ratio of 1 :1 with fucose) and the liberation of glucuronic acid to give a ratio of 0.5:1 with fucose.
Therefore the aforementioned polysaccharides are useful intermediates for preparing L- fucose.
To obtain said L-fucose, the mixture at the end of fermentation is fluidized until a viscosity below 100 cP is reached, by adding an aqueous solution of a strong acid, preferably sulphuric acid, preferably with a concentration between 30 and 70 wt.%, up to a pH between 1.5 and 4.5, preferably between 2.0 and 3.0.
The acidified mixture is then heated at temperatures between 60 and 80°C, for times between 2 and 10 hours, preferably for 4-8 hours.
The first purification step is another crucial point of the process: the polysaccharide is recovered by ultrafiltration since it remains quantitatively in the retentate together with just the cells of the microorganism while all the fermentation by-products (e.g. butanediol, lactic acid etc.) and the salts and the acid added for fluidization are removed almost quantitatively in the permeate. This step provides an excellent solution to the problem of purification of L-fucose, for obtaining a crystalline product of high purity; in fact it allows the sugars constituting the polysaccharide to be separated from all the low molecular weight by-products, for example butanediol, that cannot be removed in the steps described next, and that constitute a great problem for direct crystallization of the product, as they are present in considerable amounts.
The purification process is carried out on the retentate containing the polysaccharide according to known procedures (see for example EP102535, H. Voelskow and M. Schlingmann).
Complete hydrolysis is performed by treatment with a strong acid (for example sulphuric acid, hydrochloric acid, phosphoric acid, trifluoroacetic acid etc.). Sulphuric acid is preferred. Preferably a solution of strong acid at 30-70 wt.% is added to the retentate and it is heated at the reflux temperature for 5-10 hours. At the end of hydrolysis the mixture is neutralized by adding a base (sodium hydroxide, calcium hydroxide etc.). Calcium hydroxide is preferred.
In a preferred embodiment of the invention, sulphuric acid and calcium hydroxide are used in combination: this leads to precipitation of CaS04, which is removed by filtration or by centrifugation, thus removing a large part of the salts present in the reaction mixture.
Selective removal of D-glucose and D-galactose and glucuronic acid from the mixture is achieved by techniques known by a person skilled in the art, for example by chromatography or, preferably, by the action of a microorganism that utilizes said carbohydrates as a carbon source for growing, but leaves the L-fucose intact. Preferably, a microorganism is used and even more preferably the solution is inoculated with Saccharomyces cerevisiae.
Fermentation is conducted until glucose and galactose and glucuronic acid disappear completely. The solution is then pasteurized at 60-70°C for 10-30 minutes and the yeast cells are removed from the solution of L-fucose by ultrafiltration or microfiltration, and the ultrafiltered or microfiltered solution is deionized by passing over strong cationic and weak anionic ion exchange resins in series.
The deionized solution is concentrated to a syrup and L-fucose (whose HPLC purity in the solution at this stage is above 75%) is crystallized by adding solvent, for example alcohols such as methanol, ethanol, n-propanol, isopropanol or 2-butanone.
The present invention may be better understood from the following examples.
EXPERIMENTAL SECTION EXAMPLE 1
Isolation and purification of the C2B2 strain
The strain producing the polysaccharide containing L-fucose was isolated from 1 g of foliar homogenate of Phalaenopsis sp. (Orchidacea) in saline and diluted serially in the same solution to 10~8. 1 ml of each dilution was seeded at depth in Petri dishes containing 15 ml of TSB medium (Trypticase Soy Broth, Biolife) solidified with 15g/l of agar and left to incubate at 30°C for three days.
The yellow pigmented colonies, clear and of large convex dimensions, that develop on the surface of the agar were then transferred to fresh TSB medium for purification by smearing them for three successive cycles, starting each time from a well isolated colony.
The purity of the strain was also verified by means of observation with the light microscope, while production of the polysaccharide was tested by flask culture on a suitable medium, verifying the increase in viscosity of the culture and determining the percentage by weight of L-fucose, by HPLC on a sample that was submitted to complete hydrolysis
Once purified, the strain was submitted to summary identification by the usual methods of biochemical characterization (API tests) and by sequencing the ribosomal RNA 16S (SEQ ID NC ).
The purified strain was stored in glycerol both at -20°C and at -80 °C.
EXAMPLE 2
Production of L-fucose in a flask
In a 3-litre flask, 1 litre of culture medium is prepared, composed of:
- calcium carbonate 5g/l
- yeast extract 5g/l
- demineralized water to give a volume of 1 I
Sterilize the medium in autoclave at 121 °C for 20 minutes. Cool and add 50 ml of a sterile solution at 50% w/v of glucose: there is a final glucose concentration of 25g/l in the medium.
Inoculate the flask with 0.5 ml of glycerolate stored at -20°C of the C2B2 strain and maintain the culture in growth in the oscillating incubator at a temperature of 30°C for 48 hours. An aliquot of the fermentation broth was submitted to hydrolysis by adding 96% sulphuric acid in amounts to give a final solution of 1 .5 M, which is then heat-treated at 100<€ for 30 minutes.
HPLC analysis of the hydrolysate produces the following results (comparing only the content of glucose, galactose and fucose after hydrolysis of the fermentation broth without treatments of purification and isolation of the components)
[Glucose] = 0.09%
[Galactose] = 0.05%
[Fucose] = 0.06%
The molar proportions of Glucose:Galactose:Fucose are thus found to be 1 .8 : 1 : 1 .3.
EXAMPLE 3
Production of L-fucose at the pilot scale in a 250-I fermenter with feeding of glucose In a 250-I fermenter, 1 10 I of culture medium is prepared, composed of:
- demineralized water 1 10 1
- yeast extract 550g
- calcium carbonate 550g
Sterilize the culture medium by heating it to 121 °C for about 30 minutes (pressure 1.2- 1 .4 bar).
Cool and add 5.5 litres of a sterile solution of glucose at 50% w/v.
Inoculate with 3 litres of preferment prepared according to Example 2 and leave to stand at 30°C, stirring vigorously, blowing-in air from below, at slight pressure, monitoring the glucose concentration. When glucose is absent, add 5.5 litres of a sterile solution of glucose at 50% w/v, monitoring the pH, which must be at 7.0 ± 0.3, and the viscosity of the medium.
After 48 hours from the start of fermentation, add a further aliquot of 5.5 litres of a sterile solution of glucose at 50% w/v. Continue fermentation until the glucose disappears. The viscosity of the medium at the end of fermentation is 2500 cP. An aliquot of the fermentation broth is submitted to hydrolysis by adding 96% sulphuric acid in amounts to give a final solution of 1 .5 M and is then heat-treated at 100°C for 30 minutes. HPLC analysis gives the following results: (comparing only the content of glucose, galactose and fucose after hydrolysis of the fermentation broth without treatments of purification and isolation of the components)
[Glucose] = 0.58%
[Galactose] = 0.17%
[Fucose] = 0.34% (concentration in the broth= 3.4g/l)
The molar proportions of Glucose:Galactose:Fucose are found to be: 3.4 : 1 : 2.2
EXAMPLE 4
Production of L-fucose in a 20 m3 fermenter
In a 3000-litre fermenter, 1 000 litres of culture medium is prepared, which will serve as preferment, composed of:
- demineralized water 1000 I
- yeast extract 5 kg
- calcium carbonate 5 kg
Sterilize the culture medium by heating to 121 °C for about 30 minutes (pressure 1 .2-1 .4 bar).
Cool to 35°C and add 50 litres of sterile solution of glucose at 50% w/v. Inoculate 1000 I of the culture medium in sterile conditions with 5 litres of culture prepared according to Example 2.
Once inoculated, the preferment is left at 30°C with stirring, blowing-in air from below and under slight pressure for about 24 hours.
An aliquot of the preferment is submitted to hydrolysis by adding 96% sulphuric acid as in example 2. HPLC analysis of the hydrolysate shows the following results: (comparing only the content of glucose, galactose and fucose after hydrolysis of the fermentation broth without treatments of purification and isolation of the components) [Glucose] = 0.28%
[Galactose] = 0.09%
[Fucose] = 0.14% = 1 .4g/l
The molar proportions of Glucose:Galactose:Fucose in the preferment are found to be: 3.1 : 1 : 1 .7
Prepare the 20 m3 fermenter, charging:
- demineralized water 15 m3
- yeast extract 75 kg
- calcium carbonate 75 kg
Sterilize the culture medium by heating to 1 21 °C for about 30 minutes. Cool and add 750 I of a sterile solution of glucose at 50% w/v.
With 600 I of the preferment prepared according to the procedure described above, inoculate 15 m3 of culture medium and leave to stand at 30°C, stirring vigorously, and blowing-in air from below under slight pressure. When the glucose is no longer present, add 750 litres of a sterile solution of glucose at 50% w/v, monitoring the pH, which must be at 7.0 ± 0.3 and the viscosity of the medium.
After 48 hours from the start of fermentation, add a further aliquot of 750 litres of a sterile solution of glucose at 50% w/v.
Continue fermentation until the glucose disappears.
The fermentation takes a total of 140 hours.
At the end of fermentation an aliquot of the fermentation broth is submitted to hydrolysis by adding 96% sulphuric acid as in example 2. HPLC analysis of the hydrolysate shows the following results: (comparing only the content of glucose, galactose and fucose after hydrolysis of the fermentation broth without treatments of purification and isolation of the components) [Glucose] = 0.27%
[Galactose] = 0.10%
[Fucose] = 0.18%
The molar proportions of Glucose:Galactose:Fucose are found to be 2.7 : 1 : 2.0 The fermentation is then stopped and the ferment is fluidized by adding 50% sulphuric acid to pH = 2.8.
EXAMPLE 5
Recovery, purification and crystallization of L-fucose
15 m3 of ferment obtained from Example 4 (containing 28 kg of L-fucose) is ultrafiltered for the purpose of separating and concentrating the polysaccharide. 315 kg of 50% sulphuric acid is added to the retentate from ultrafiltration, maintaining the suspension under reflux for 8 hours in a suitable reactor, for complete hydrolysis of the polysaccharide.
After it has been brought back to room temperature, the suspension is adjusted to pH 5.5-6.5, by adding 180 kg of calcium hydroxide.
The precipitate of calcium sulphate that forms after adding calcium hydroxide is removed by centrifugation.
The supernatant is then adjusted to 37 °C, and inoculated with 2 kg of lyophilized yeast Saccharomyces cerevisiae.
After about 18 hours the glucose and galactose have been consumed.
The solution is then pasteurized at 70°C for 30 minutes and ultrafiltered. The ultrafiltration permeate is deionized on strong cationic and weak anionic ion exchange resins in series.
At this point the solution is treated with nanofiltration membrane (membrane SR2 Kock Membrane Systems, Milan) and the permeate is then concentrated by evaporation under vacuum to 75°Brix.
The fucose is crystallized by adding 140 I of ethanol: the mixture is heated with stirring to dissolve the syrup in the solvent and is then cooled to crystallize the fucose. After 72 hours the solid is filtered in vacuum and is washed with ethanol. Once dried, the crystalline fucose weighs 22.7 kg (yield = 81 %) and has HPLC titre > 99.5% and purity in HPLC area > 99.9%.
Analysis by 1 H and 13C NMR and measurement of the rotatory power (value obtained for [alpha] D at 20°C in water, at equilibrium = -75.0° ± 2) confirmed that the product isolated is L-fucose (6-deoxy-L-galactose).
EXAMPLE 6
Isolation of the polysaccharide or mixture of polysaccharides obtained from fermentation of the C2B2 strain and analysis bv 1 H- and 13C-NMR spectrometry
The fermentation of the C2B2 strain was carried out as in example 4.
30% sulphuric acid was added to the fermentation broth until a pH of 2.9 was reached. The solution was maintained at room temperature for about 48 hours and then a further amount of 50% sulphuric acid was added to it until a pH of 1 .5 was reached.
The solution was then concentrated and diafiltered by ultrafiltration with a polymer membrane with a molecular cut-off of 10 000 Da.
2 litres of retentate were centrifuged at 13 000 rpm for 20 minutes at 20°C and the supernatant was filtered on a dicalite panel and on a filter with porosity of 0.8 μιη. The filtration permeate was neutralized to pH 6.9 by adding 32% sodium hydroxide, diafiltered against demineralized water and concentrated by tangential ultrafiltration with a spiral-wound membrane of 20 000 Da, and finally dried to constant weight in a rotary evaporator (Rotovapor, Buchi).
To 100 mg of sample, dissolved in 0.75 ml of deuterated water, 4μΙ of acetonitrile was added as internal standard (1 H-NMR 6=2.060ppm; 13C-NMR 8=1.470ppm).
The 1 H-NMR spectra were recorded on a model VXR300S Varian spectrometer (Varian Inc., Palo Alto CA, USA) with the following settings:
The 1 H-NMR spectrum obtained is shown in Fig. 1 .
The 13C-NMR spectra were recorded on a model VXR300S Varian spectrometer (Varian Inc., Palo Alto CA, USA) with the following settings:
temp (<C) 25
The 13C-NMR spectra obtained are shown in Fig. 2 and Fig. 3 (where only the anomeric region of the spectrum is presented)
EXAMPLE 7
Purification and partial hydrolysis of the polysaccharide or mixture of polysaccharides obtained from fermentation of the C2B2 strain and analysis by HPLC chromatography The fermentation of the C2B2 strain was carried out as in example 4.
2.5 litres of fermentation broth, diluted with an equal volume of demineralized water, was centrifuged at 13 000 rpm for 20 minutes at room temperature.
Glacial acetic acid was added to the supernatant until a final concentration of 2% was reached. The sample was then heated at 100<€ for 1 hour.
After neutralization with sodium hydroxide to pH 6.5, the sample was centrifuged again at 13000 rpm for 30 minutes and, after dilution 1 :1 with water, it was diafiltered against demineralized water and concentrated by tangential ultrafiltration with a spiral-wound membrane with molecular cut-off of 20000 Da.
The concentrate was dried to constant weight in a rotary evaporator (Rotovapor, Buchi). 5 grams of sample was treated with trifluoroacetic acid (TFA) to a final concentration of 16% in autoclave (2 atm) at 121 °C for 20 minutes. The solution obtained was exchanged with 100 ml of demineralized water by means of the rotary evaporator (Rotovapor, Buchi) 5 times.
The sample was then submitted to HPLC chromatographic analysis using the Perkin Elmer series 200 HPLC chromatograph, chromatographic column Transgenomic ICE- SEP ION 300 equipped with similar precolumn and refractive index detector with thermostatically controlled cells.
Separation was performed with 0.015 N sulphuric acid as mobile phase and with the column thermostatically controlled to a temperature of 40 °C. The chromatogram is shown in Fig. 4. In addition to the characteristic peaks of monosaccharides obtained after hydrolysis, a peak is seen at 10.62 minutes (so-called peak at 11) (see printout below).
I Peak j Time Component Concentration Area ! Response Amount Area Delta RT # [min] Name % [μ Vs] ! factor [Norm. %] [%] I [%]
1: 9.848! -7.05e-95 705035 !-1.00e+100 i 4.17;
2j 10.621 i Peak at 11 min 0.374831 3222068! 8.5961 e+06 j 18.5! 19.08; 1.4789
3! 11.765! 0.006163 52981; 8.5961 e+06 j 0.3 j 0.31; 2.2966
4j 11.953! 0.008062 69300! 8.5961 e+06 j 0.4! 0.41; -2.4059
5! 12.728! GlucNa 0.051417 4419828.5961Θ+06 j 2.5 j 2.62; -0.5640
6: 13.319! -1.24e-95 123790 j-1.00e+100 i 0.73;
7i 13.614! 0.119755 375802! 3.1381 e+06 j 5.9! 2.23; -0.6280
8! 14.627! Glucose 0.367912 2957295! 8.0381 e+06 j 18.2 j 17.51; -0.0256
9j 15.819; Galactose 0.457796 37583368.2096e+06 j 22.6! 22.25; -0.0703
10! 18.523! Fucose 0.623248 51227428.2194e+06 j 30.8; 30.33; -0.0487
11 i 20.336! 0.006238 19575! 3.1381 e+06 i 0.3 j 0.12; 0.8710
12; 22.168! 0.003998 112202.8068e+06 j 0.2; 0.07; -2.3443
13! 25.862! -2.07e-98 207 -1.00e+100 j o.oo ;
14; 27.863! 0.003977 28951! 7.2791 e+06 j 0.2; 0.17; -4.1787
15! 34.852! -4.35e-99 43 -1.00e+100 j 3e-04;
2.023395 16889328! 100.0; 1e+02; However, the chromatogram given in Fig.5 shows the HPLC plot obtained in the same conditions on the same sample after elimination of the peak at 11 by passing over ion exchange resins.
In this case the sample obtained after partial hydrolysis was in fact treated with a pair of ion exchange resins Amberlite IR 120 (Rohm and Haas) and Amberlite IRA 94S (Rohm and Haas) to remove the peak at 11 minutes,
(see printout below)
; Peak ; Time Component ; Concentration i Area Response ; Amount ; Area ! Delta RT
# [min] Name % [ vs] ! factor [Norm. ] ! [%] [%]
1 10.608 Peak at 11 min ; 0.003264; 28053: 8.5961 e+06 ; 0.3! 0.30; 1.3523
2 12.023 0.026459: 227440: 8.5961 e+06 : 2.1; 2.42: -1.8368
3 12.685 GlucNa 0.043995; 378183; 8.5961 e+06 \ 3.6: 4.03; -0.8983
4; 13.565 0.139027; 436280: 3.1381 e+06 : 11.2! 4.64; -0.9885
5 14.641 Glucose 0.299055! 2403819! 8.0381 e+06 \ 24.2: 25.59! 0.0689
6 15.835 Galactose 0.326105: 2677203: 8.2096e+06 \ 26.4! 28.50; 0.0338
7 18.537 Fucose 0.392409: 3225376: 8.2194e+06 : 31.8; 34.33 ! 0.0219 8 20.328 0.005591 : 17544 : 3.1381e+06 \ 0.5 ; 0.19 ; 0.8350
1.235903 9393900 ; 100.0 ; 1e+02 ;
EXAMPLE 8
Purification and complete hydrolysis of the polysaccharide or mixture of polysaccharides obtained from fermentation of the C2B2 strain and analysis by HPLC chromatography
The fermentation of the C2B2 strain was carried out as in example 4.
30% sulphuric acid was added to an aliquot of the fermentation broth to obtain a final pH of the solution of 3.0.
The solution obtained was ultrafiltered by filtration on a ceramic filter with cut-off of 300 000 Da (0.05 micron) and the permeate was concentrated using a nanofiltration membrane (SR2 membrane).
The polysaccharide was then precipitated with methanol (final concentration methanol :water of 3:1 ).
The precipitate was finally filtered on a paper filter, washed with a solution of methanol :water 3:1 and dried in a stove at 40°C for 8 hours.
100 mg of sample was treated with trifluoroacetic acid (TFA) at a final concentration of 50% in autoclave (2 atm) at 121 °C for 60 minutes.
The sample was then submitted to HPLC chromatographic analysis using the Perkin Elmer series 200 HPLC chromatograph, chromatographic column Transgenomic ICE- SEP ION 300 equipped with similar precolumn and refractive index detector with thermostatically controlled cells.
Separation was performed with 0.015 N sulphuric acid as mobile phase and with column thermostatically controlled to a temperature of 40 °C.
The chromatogram is shown in Fig. 6 (where the so-called peak at 1 1 is practically absent).
(see printout below) Peak : Time ; Component Concentration Area Response i Amount Area
# [min] Name % factor [Norm. %] [%]
\ 1 ; 10.774 Peak at 1 1 min 0.012626 20626 9.0508e+06 \ 0.7 0.79
\ 2 \ 1 1.949 0.001294 21 14 9.0508e+06 \ 0.1 0.08
\ 3 i 12.914 Glucuronic 0.137319 171335 6.9130e+06 \ 7.5 6.55
\ 4 ; 14.806 Glucose 0.320998 484912 8.3698e+06 \ 17.5 18.54
5 16.015 ; Galactose 0.670134 1044233 8.6335e+06 i 36.4 39.93
j 6 ; 17.357 0.002600 4027 8.5828e+06 \ 0.1 0.15
; 7 \ 18.742 Fucose 0.474430 725582 8.4736e+06 \ 25.8 27.74
\ 8 i 20.399 0.022124 12531 3.1381 e+06 i 1.2 0.48
! 9 : 22.446 0.122837 62229 2.8068e+06 \ 6.7 2.38
\ 10 i 26.291 0.013841 7840 3.1381 e+06 i 0.8 0.30
\ 11 i 28.231 0.060735 79793 7.2791 e+06 : 3.3 3.05
1.838938 \ 2615221 100.0
EXAMPLE 9
Purification and partial hydrolysis of the polysaccharide or mixture of polysaccharides obtained from fermentation of the C2B2 strain and analysis by HPLC chromatography with column thermostatically controlled to 50 °C
The fermentation of the C2B2 strain was carried out as in example 4.
50% sulphuric acid was added to an aliquot of the fermentation broth to obtain a final pH of the solution of 1.5.
The solution was then heated at 97 °C for 6 hours.
After cooling to room temperature the solution was neutralized to pH 5.0 by adding calcium hydroxide and centrifuged at 13 000 rpm for 20 minutes.
The sample was then submitted to HPLC chromatographic analysis using the Perkin Elmer series 200 HPLC chromatograph, chromatographic column Transgenomic ICE- SEP ION 300 equipped with similar precolumn and refractive index detector with thermostatically controlled cells.
Separation was performed with 0.015 N sulphuric acid as mobile phase and with column thermostatically controlled to a temperature of 50 °C.
The chromatogram is shown in Fig. 7. (see printout below)

Claims

1 . An isolated microbial strain, belonging to Enterobacteriaceae family, comprising an rRNA 16S sequence containing a sequence having homology with SEQ. ID NO: 1 equal or greater than 93%; said bacterial strain being able to produce extracellular polysaccharides containing L-Fucose, when subjected to aerobic fermentation.
2. A microbial strain according to claim 1 , comprising an rRNA 16S sequence containing a sequence having homology with SEQ. ID NO: 1 equal or greater than 98%.
3. A microbial strain according to claim 2, wherein the rRNA 16S sequence comprises SEQ. ID No: 1.
4. A bacterial strain according to claim 3 deposited at DSMZ under the registration number DSM 22227.
5. A derived or mutated microbial strain obtainable from a bacterial strain according to any one of the claims 1 -4, by selecting spontaneously mutated and isolated strains or by selecting strains mutated by the action of mutagenic factors such as UV or X rays, or by the action of chemicals such as ozone, nitrous acid, N- methyl-N-nitro-N-nitrosoguanidine (NTG) or ethane methane sulfonate (EMS); said derived or mutated strain being able to produce extracellular polysaccharides containing L-Fucose, when subjected to aerobic fermentation.
6. A derived or mutated microbial strain according to claim 5, comprising an rRNA 16S sequence containing a sequence having homology with SEQ. ID NO: 1 equal or greater than 98%.
7. Extracellular polysaccharides containing L-fucose, obtainable through aerobic fermentation from any one of the microbial strains according to any one of the claims 1 -6.
8. Polysaccharides according to claim 7 containing D-Glucose, D-Galactose, L- Fucose and preferably glucuronic acid and pyruvic acid as well.
9. Polysaccharides according to any one of the claims 7-8, wherein 1 H- and 13C- NMR spectra comprise the following characteristic signals:
1. 1 H-NMR: 1 .3 ppm, 5.0 ppm, 5.3 ppm and 5.5 ppm;
2. 13C-NMR: 15.9 ppm, 100.0 ppm and 104,5 ppm.
10. Use of a polysaccharide or mixture of polysaccharides according to any one of the claims 7-9 for preparing L-fucose.
1 1. A process for producing at least one polysaccharide according to any one of the claims 7-9, said process comprising the aerobic fermentation of an inoculum of a microbial strain according to any one of the claims 1 -6 in any fermentable aqueous medium containing carbon and nitrogen sources and mineral salts; said fermentation conducted at temperatures from 25 and 35°C, and pH from 6.0 and 7.5, with aeration and stirring, over a period of 2-7 days.
12. A process for producing L-Fucose, said process comprising the hydrolysis of at least one polysaccharide according to any one of the claims 7-9.
13. A process according to claim 12, said process further comprising the aerobic fermentation according to claim 1 1.
14. A process according to claim 13 comprising the following steps:
a. inoculation into any fermentable aqueous medium containing carbon and nitrogen sources and mineral salts;
b. fermentation of the mixture obtained from step (a), at temperatures from 25 and 35°C, and pH from 6.0 and 7.5 with aeration and stirring, over a period of 2-7 days;
c. adding an aqueous solution of strong acid up to pH from 1 .5 to 4.5 for fluidifying the mixture obtained from step (b) to obtain a viscosity lower than 100 cps;
d. heating the mixture obtained from step (c), at temperatures from 60 to 80Ό, over time periods from 2 to 10 hrs;
e. ultrafiltration of the mixture obtained from step (d) to obtain a retentate containing at least one polysaccharide containing L-fucose;
f. hydrolysis of the retentate, obtained from step (e), by treating with a strong acid, preferably H2S04, at reflux temperature in an aqueous solvent, to obtain a mixture mainly containing D-Glucose, D-Galactose and L-Fucose; g. neutralization of the mixture obtained from step (f), by adding a base, preferably Ca(OH)2;
h. filtration or centrifugation to eliminate possible precipitated salts followed by a further neutralization carried out as step (g);
i. selectively eliminating Glucose and Galactose from the mixture obtained from step (h), by means of known techniques to obtain a mixture essentially containing L-Fucose;
j. deionization by means of strong cation exchange resins and weak anion exchange resins arranged in series,
k. isolating L-Fucose.
EP11769803.5A 2010-09-13 2011-09-13 Process for production of l-fucose Withdrawn EP2616547A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI2010A000188A IT1405680B1 (en) 2010-09-13 2010-09-13 PROCESS FOR THE PRODUCTION OF L-FUCOSIUM.
PCT/EP2011/065825 WO2012034996A1 (en) 2010-09-13 2011-09-13 Process for production of l-fucose

Publications (1)

Publication Number Publication Date
EP2616547A1 true EP2616547A1 (en) 2013-07-24

Family

ID=43430775

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11769803.5A Withdrawn EP2616547A1 (en) 2010-09-13 2011-09-13 Process for production of l-fucose

Country Status (3)

Country Link
EP (1) EP2616547A1 (en)
IT (1) IT1405680B1 (en)
WO (1) WO2012034996A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20120052A1 (en) * 2012-03-13 2013-09-14 Inalco Spa PROCESS FOR RECOVERY OF L-FUCOSIO FROM ESOPOLISACCARIDES.
EP2676536A1 (en) 2012-06-22 2013-12-25 AIT Austrian Institute of Technology GmbH Method for producing plant seed containing endophytic micro-organisms
DK2728009T3 (en) 2012-10-31 2017-11-06 Jennewein Biotechnologie Gmbh Process for the preparation of monosaccharides
BR112015018618B1 (en) 2013-02-05 2022-08-30 University Of Saskatchewan COMPOSITION AND METHODS TO IMPROVE SEED VITALITY, HEALTH AND/OR YIELD OF A PLANT
US10136646B2 (en) 2013-06-26 2018-11-27 Indigo Ag, Inc. Agricultural endophyte-plant compositions, and methods of use
MX2020003138A (en) 2013-06-26 2021-03-25 Indigo Ag Inc Seed-origin endophyte populations, compositions, and methods of use.
AU2014315191A1 (en) 2013-09-04 2016-04-21 Indigo Ag, Inc. Agricultural endophyte-plant compositions, and methods of use
WO2015032412A1 (en) 2013-09-06 2015-03-12 Glycom A/S Fermentative production of oligosaccharides
US10813359B2 (en) 2013-11-06 2020-10-27 The Texas A & M University System Fungal endophytes for improved crop yields and protection from pests
US9364005B2 (en) 2014-06-26 2016-06-14 Ait Austrian Institute Of Technology Gmbh Plant-endophyte combinations and uses therefor
EP3086646A4 (en) 2013-12-24 2017-08-09 Indigo AG, Inc. Plants containing beneficial endophytes
WO2015100432A2 (en) 2013-12-24 2015-07-02 Symbiota, Inc. Method for propagating microorganisms within plant bioreactors and stably storing microorganisms within agricultural seeds
AU2015278238B2 (en) 2014-06-20 2018-04-26 The Flinders University Of South Australia Inoculants and methods for use thereof
US10212911B2 (en) 2014-06-26 2019-02-26 Indigo Agriculture, Inc. Endophytes, associated compositions, and methods of use thereof
ES2933616T3 (en) * 2014-12-16 2023-02-10 Glycom As Separation of 2'-FL from a fermentation broth
CA3060491A1 (en) 2014-12-30 2016-07-07 Servicenow, Inc. Failure resistant distributed computing system
EP3050973A1 (en) 2015-01-30 2016-08-03 Jennewein Biotechnologie GmbH Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars
KR102584658B1 (en) 2015-03-26 2023-10-04 바스프 에스이 Biocatalytic production of l-fucose
CA2984493A1 (en) 2015-05-01 2016-11-10 Indigo Agriculture, Inc. Isolated complex endophyte compositions and methods for improved plant traits
AU2016258913B2 (en) 2015-05-01 2019-11-07 Indigo Ag, Inc. Designed complex endophyte compositions and methods for improved plant traits
CA2988764A1 (en) 2015-06-08 2016-12-15 Indigo Agriculture, Inc. Streptomyces endophyte compositions and methods for improved agronomic traits in plants
AU2016378742A1 (en) 2015-12-21 2018-07-12 Indigo Ag, Inc. Endophyte compositions and methods for improvement of plant traits in plants of agronomic importance
US11312741B2 (en) 2016-04-19 2022-04-26 Glycom A/S Separation of oligosaccharides from fermentation broth
US10624351B2 (en) 2016-12-01 2020-04-21 Indigo Ag, Inc. Modulated nutritional quality traits in seeds
US11807586B2 (en) 2016-12-23 2023-11-07 The Texas A&M University System Fungal endophytes for improved crop yields and protection from pests
RU2019129891A (en) 2017-03-01 2021-04-01 Индиго Аг, Инк. ENDOPHYTIC COMPOSITIONS AND METHODS FOR IMPROVING PLANT SIGNS
CN110582205A (en) 2017-03-01 2019-12-17 靛蓝股份公司 Endophytic plant composition and method for improving plant traits
BR112019022446B1 (en) 2017-04-27 2024-01-16 The Flinders University Of South Australia COMPOSITIONS OF STREPTOMYCES BACTERIAL INOCULANTS AND METHOD FOR CONTROLLING FUNGAL ROOT DISEASE IN WHEAT OR CANOLA
US11263707B2 (en) 2017-08-08 2022-03-01 Indigo Ag, Inc. Machine learning in agricultural planting, growing, and harvesting contexts
EA202090605A1 (en) 2017-09-22 2020-06-26 Технише Универзитэт Грац POLYMER PARTICLES CONTAINING MICRO-ORGANISMS
EP3486326A1 (en) * 2017-11-21 2019-05-22 Jennewein Biotechnologie GmbH Method for the purification of n-acetylneuraminic acid from a fermentation broth
US20220081732A1 (en) * 2019-01-21 2022-03-17 Dupont Nutrition Biosciences Aps Process for making l-fucose
WO2021196572A1 (en) * 2020-03-30 2021-10-07 西南大学 Fucose-rich extracellular polysaccharide, preparation method therefor and application thereof
CN114835766A (en) * 2022-05-20 2022-08-02 中国科学院力学研究所 Method for separating L-fucose from binary mixture

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298691A (en) 1980-09-05 1981-11-03 Merck & Co., Inc. Preparation of heteropolysaccharide S-156
DE3300633A1 (en) * 1982-08-10 1984-03-01 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING RHAMNOSE OR FUCOSE
US4806636A (en) * 1985-03-20 1989-02-21 The Dow Chemical Company Heteropolysaccharide produced by Enterobacter sakazakii
FR2729969B1 (en) * 1995-01-26 1997-04-18 Bieurope NEW STRAIN OF KLEBSIELLA PNEUMONIAE, SUBSP. PNEUMONIAE AND PROCESS FOR PRODUCING L-FUCOSE-CONTAINING POLYSACCHARIDE
US6713287B1 (en) 1995-10-24 2004-03-30 The Scripps Research Institute Enzymatic synthesis of L-fucose and L-fucose analogs
KR100397793B1 (en) * 2000-07-28 2003-09-13 삼성전자주식회사 Novel Microorganism Isolated from Chinese elm(Ulmus sp.) and Process for Preparing Immunostimulating Exopolysaccharides with Anti-cancer Activity by Employing the Microorganism
FR2840920B1 (en) * 2002-06-18 2006-06-23 Biochimie Appliquee Soc NEW MICROORGANISM OF THE ENTEROBACTERIACEAE FAMILY
FR2842201B1 (en) * 2002-06-18 2005-01-14 Probest NOVEL OLIGOSACCHARIDE, COSMETIC AND / OR DERMATOLOGICAL COMPOSITIONS CONTAINING THE SAME AND ITS APPLICATIONS
JP2004208563A (en) * 2002-12-27 2004-07-29 Asahi Kasei Corp New bacterium, water-soluble polysaccharide and method for producing the same
PT104888B (en) * 2009-12-15 2020-09-10 73100 - Setenta E Três Mil E Cem, Lda BACTERIAL BIOPOLYMER CONTAINING FUCOSE

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FILOMENA FREITAS ET AL: "Fucose-containing exopolysaccharide produced by the newly isolated Enterobacter strain A47 DSM 23139", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 83, no. 1, 23 July 2010 (2010-07-23), pages 159 - 165, XP002638650, ISSN: 0144-8617, [retrieved on 20100723], DOI: 10.1016/J.CARBPOL.2010.07.034 *
See also references of WO2012034996A1 *

Also Published As

Publication number Publication date
WO2012034996A1 (en) 2012-03-22
IT1405680B1 (en) 2014-01-24
ITFI20100188A1 (en) 2012-03-14

Similar Documents

Publication Publication Date Title
WO2012034996A1 (en) Process for production of l-fucose
Çoban et al. Effect of various carbon and nitrogen sources on cellulose synthesis by Acetobacter lovaniensis HBB5
EP1803820B1 (en) A process for the preparation of vitamin K2
US8685698B2 (en) Yellow pigments generation deficient Sphingomonas strain and application thereof in gellan gum production
US11591416B2 (en) Exopolysaccharides and uses thereof
US9382562B2 (en) Strains of Serratia plymuthica producing turanose and uses thereof
JPH11500609A (en) Klebsiella pneumoniae, subsp. Novel strain of Pneumoniae and method for producing polysaccharide containing L-fucose
CN111733092A (en) Fermentation process of producing polysialic acid and its extracting and refining process
HU205971B (en) Process for producing vancomycin
KR20050031212A (en) THE ISOFLAVONE-β-D-GLUCAN PRODUCED BY AGARICUS BLAZEI IN THE SUBMERGED LIQUID CULTUR AND THE PRODUCING METHOD THERE OF
US4950604A (en) Culture of a microorgansim of the genus klebsiella sp., having a high content of rhamnose
JPH02257888A (en) Production of palatinose and trehalose by microorganism
JPH03228687A (en) Production of d-psicose
Fukuoka et al. Production of dihydroxy C50-carotenoid by Aureobacterium sp. FERM P-18698
WO1996039155A1 (en) Immunopotentiator
WO1998023766A1 (en) Process for the preparation of ribitol
JPH0443637B2 (en)
KR20230081015A (en) Method for producing Polyhydroxyalkanoate from mixed alkanes
JPH046356B2 (en)
JP3063804B2 (en) Novel macrolide antibiotic SF2748 substance and method for producing the same
JP4197604B2 (en) Novel strain, novel α-glucosidase and method for producing the same
KR101081745B1 (en) Staphylococcus saprophyticus BMSZ711 producing poly-Ν-acetylglucosamine and method for producing poly―Ν―acetylglucosamine from Staphylococcus saprophyticus BMSZ711
CN115058369A (en) Preparation method of extracellular polysaccharide source fucooligosaccharide fermentation type synbiotics
CN114381480A (en) Fermentation method of sirolimus
CN116355822A (en) Recombinant bacillus subtilis for producing L-fucose and construction method and application thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130415

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140903